Impact of induction intensity and transplantation on outcomes of patients with complex karyotype and TP53-mutated acute myeloid leukemia

被引：0
|
作者：
Omer Jamy
Kendall Diebold
Kenneth Davis
Kimo Bachiashvili
Sravanti Rangaraju
Pankit Vachhani
Kelly N. Godby
Donna Salzman
Ravi Bhatia
机构：
[1] University of Alabama at Birmingham,Division of Hematology and Oncology, Department of Medicine
[2] University of Alabama at Birmingham,School of Medicine
来源：
Bone Marrow Transplantation | 2023年 / 58卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：823 / 825
页数：2
相关论文
共 50 条
  • [41] Challenges and emerging therapeutic strategies for TP53-mutated acute myeloid leukemia: still disappointing findings?
    Molica, Matteo
    EXPERT REVIEW OF HEMATOLOGY, 2025, 18 (01) : 1 - 4
  • [42] Treatment outcomes for newly diagnosed, untreated TP53-mutated acute myeloid leukemia: A systematic review and meta-analysis.
    Daver, Naval Guastad
    Iqbal, Shahed
    Renard, Camille
    Chan, Rebecca J.
    Hasegawa, Ken
    Hu, Hao
    Tse, Preston
    Yan, Jiajun
    Zoratti, Michael J.
    Xie, Feng
    Ramsingh, Giridharan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E19020 - E19020
  • [43] TP53-mutated Acute Myeloid Leukemia with Myelodysplasia-Related Changes and TherapyRelated Acute Myeloid Leukemia Have Comparable TP53 Mutational Signature and Clinical Features
    Tashakori, Mehrnoosh
    Tapan, Kadia
    Loghavi, Sanam
    Tang, Zhenya
    Routbort, Mark
    Ravandi-Kashani, Farhad
    Khoury, Joseph
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1027 - 1028
  • [44] Post-Transplant T Cell Clonotype Diversity Is Associated with Survival in Patients with TP53-Mutated Acute Myeloid Leukemia
    Sariipek, Nurefsan
    Safina, Kseniia R.
    Cutler, Corey
    Ho, Vincent T.
    Koreth, John
    Lindsley, Coleman
    Luskin, Marlise R.
    Garcia, Jacqueline S.
    Hearsey, Doreen
    Lu, Wesley S.
    Li, Shuqiang
    Livak, Kenneth J.
    Griffin, Gabriel K.
    Soiffer, Robert J.
    Ritz, Jerome
    Wu, Catherine J.
    Antin, Joseph H.
    Lane, Andrew A.
    Van Galen, Peter
    Gooptu, Mahasweta
    BLOOD, 2023, 142
  • [45] EARLY POST-TRANSPLANT IMMUNE DYNAMICS PREDICT RELAPSE RISK IN PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA
    Sariipek, Nurefsan
    Safina, Ksenia
    Li, Shuqiang
    Lu, Wesley
    Cutler, Corey
    Livak, Kenneth
    Garcia, Jacqueline
    Lindsley, Coleman
    Luskin, Marlise
    Wu, Catherine
    Ritz, Jerome
    Antin, Joseph
    Soiffer, Robert
    Lane, Andrew
    Gooptu, Mahasweta
    van Galen, Peter
    EXPERIMENTAL HEMATOLOGY, 2024, 137
  • [46] EARLY POST-TRANSPLANT IMMUNE DYNAMICS PREDICT RELAPSE RISK IN PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA
    Sariipek, Nurefsan
    Safina, Ksenia
    Li, Shuqiang
    Lu, Wesley
    Cutler, Corey
    Livak, Kenneth
    Garcia, Jacqueline
    Lindsley, Coleman
    Luskin, Marlise
    Wu, Catherine
    Ritz, Jerome
    Antin, Joseph
    Soiffer, Robert
    Lane, Andrew
    Gooptu, Mahasweta
    van Galen, Peter
    EXPERIMENTAL HEMATOLOGY, 2024, 137
  • [47] The XPO7-NPAT axis represents key vulnerabilities in TP53-mutated acute myeloid leukemia
    Semba, Yuichiro
    Yamauchi, Takuji
    Bauer, Daniel E.
    Ogawa, Seishi
    Akashi, Koichi
    Maeda, Takahiro
    CANCER SCIENCE, 2025, 116 : 139 - 139
  • [48] Clinical outcomes and characteristics of patients with TP53-mutated myelodysplastic syndromes
    Zhang, Lijuan
    Chen, Kankan
    Li, Yingying
    Chen, Qiuni
    Shi, Wenting
    Ji, Tingting
    Tao, Hong
    He, Zhengmei
    Wang, Chunling
    Yu, Liang
    HEMATOLOGY, 2023, 28 (01)
  • [49] Patients with TP53-Mutated Acute Myeloid Leukemia Receiving Intensive Induction Therapy Have Superior Outcomes Due to a Higher Rate of Salvage Therapy: A Single Institution, Retrospective Study
    Sumransub, Nuttavut
    Steinwand, Gabriel K.
    Cordner, Keith
    Lee, Yoonkyu
    Cao, Qing
    Allred, Jeremy
    Bachanova, Veronika
    Juckett, Mark
    Eckfeldt, Craig
    Maakaron, Joseph E.
    Tracy, Sean I.
    Ramesh, Vidhyalakshmi
    Nelson, Andrew C.
    Yohe, Sophia
    Sachs, Zohar
    CANCERS, 2024, 16 (16)
  • [50] TP53-mutated Acute Myeloid Leukemia with Myelodysplasia-Related Changes and Therapy-Related Acute Myeloid Leukemia Have Comparable TP53 Mutational Signature and Clinical Features
    Tashakori, Mehrnoosh
    Tapan, Kadia
    Loghavi, Sanam
    Tang, Zhenya
    Routbort, Mark
    Ravandi-Kashani, Farhad
    Khoury, Joseph
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1027 - 1028
12345